Multiple myeloma in Korea: past, present, and future perspectives. Experience of the Korean Multiple Myeloma Working Party
2010; Springer Science+Business Media; Volume: 92; Issue: 1 Linguagem: Inglês
10.1007/s12185-010-0617-6
ISSN1865-3774
AutoresJae Hoon Lee, Dong Soon Lee, Je Jung Lee, Yoon Hwan Chang, Jong‐Youl Jin, Deog‐Yeon Jo, Soo‐Mee Bang, Hyo Jung Kim, Jin Seok Kim, Kihyun Kım, Hyeon Seok Eom, Chang Ki Min, Sung Soo Yoon, Sun Hee Kim, Cheolwon Suh, Kyung Sam Cho,
Tópico(s)Malaria Research and Control
ResumoThe incidence of multiple myeloma suggests an ethnic difference. Compared to Caucasians, who have an incidence rate of 3–5/100,000, Asians show much lower incidence rate compared to them, in the range of 0.5–3/100,000. In Korea, The very first case report of multiple myeloma was published in 1959 [1], and was followed by a few case reports until the 1970s. Since that time, the number of cases of multiple myeloma in Korea increased steadily, reaching 100 cases/year in 1990 [2] and 500 cases/year in 2000 [3], and it is still going up. Currently in Korea, 1,000 patients are estimated to be diagnosed with multiple myeloma, and 700 patients are assumed to die of this disease every year, and 4,000–5,000 patients are suffering from this disease [4]. The most updated, age-standardized, incidence rate of multiple myeloma in Korea is 1.4/100,000, and ranked as the third most common among the hematologic malignancies, only surpassed by non-Hodgkin’s lymphoma and acute myeloid leukemia [5]. Besides, the mortality from multiple myeloma
Referência(s)